Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism

Molecular Biology of the Cell

Volumn 13, Issue 12, 2002, Pages 4206-4220

  Staleva, Liliana ^a   Manga, Prashiela ^a   Orlow, Seth J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIVICIN; ARSENIC; CHLOROBIMANE; DYE; ENZYME INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; METAL DERIVATIVE; MONOPHENOL MONOOXYGENASE; PINK EYED DILUTION PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VACUOLAR GAMMA GLUTAMYLCYSTEINE TRANSPEPTIDASE; ACID PHOSPHATASE; CARRIER PROTEIN; MEMBRANE PROTEIN; MEPACRINE; OCA2 PROTEIN, HUMAN; P PROTEIN, MOUSE; SUCROSE; THIOL DERIVATIVE;

ANIMAL CELL; ARSENIC POISONING; ARTICLE; CELL CULTURE; CELL METABOLISM; EYE DEVELOPMENT; GENE MUTATION; GENETIC DISORDER; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOSOME; MOUSE; NONHUMAN; P GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; SACCHAROMYCES CEREVISIAE; YEAST; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL FRACTIONATION; DENSITY GRADIENT CENTRIFUGATION; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; GENE VECTOR; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; MELANOCYTE; METABOLISM; MUTATION; OPEN READING FRAME; PH; PHYSIOLOGY; PLASMID; TIME; TRANSPORT AT THE CELLULAR LEVEL;

SACCHAROMYCES CEREVISIAE;

ACID PHOSPHATASE; ANIMALS; ARSENIC; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CENTRIFUGATION, DENSITY GRADIENT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC VECTORS; GENOTYPE; GLUTATHIONE; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; MELANOCYTES; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MUTATION; OPEN READING FRAMES; PLASMIDS; QUINACRINE; SACCHAROMYCES CEREVISIAE; SUBCELLULAR FRACTIONS; SUCROSE; SULFHYDRYL COMPOUNDS; TIME FACTORS;

EID: 0036911335     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-05-0282     Document Type: Article

References (84)

1. Ancans, J., Hoogduijn, M.J., and Thody, A.J. (2001). Melanosomal pH, pink locus protein and their roles in melanogenesis. J. Invest. Dermatol. 117, 158-159.
2. Anderson, M.E. (1985). Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113, 548-555.
3. Awasthi, S., Singhal, S.S., Srivastava, S.K., Zimniak, P., Bajpai, K.K., Saxena, M., Sharma, R., Ziller, S.A., 3rd, Frenkel, E.P., and Singh, S.V. (1994). Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J. Clin. Invest. 93, 958-965.
4. Benedetto, J.P., Ortonne, J.P., Voulot, C., Khatchadourian, C., Prota, G., and Thivolet, J. (1981). Role of thiol compounds in mammalian melanin pigmentation: Part I. Reduced and oxidized glutathione. J. Invest. Dermatol. 77, 402-405.
5. Benedetto, J.P., Ortonne, J.P., Voulot, C., Khatchadourian, C., Prota, G., and Thivolet, J. (1982). Role of thiol compounds in mammalian melanin pigmentation. II. Glutathione and related enzymatic activities. J. Invest. Dermatol. 79, 422-424.
6. Bennett, D.C., Cooper, P.J., and Hart, I.R. (1987). A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumor promoter for growth. Int. J. Cancer 39, 414-418.
7. Bittinger, F., Gonzalez-Garcia, J.L., Klein, C.L., Brochhausen, C., Offner, F., and Kirkpatrick, C.J. (1998). Production of superoxide by human malignant melanoma cells. Melanoma Res. 8, 381-387.
8. Boeke, J.D., LaCroute, F., and Fink, G.R. (1984). A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197, 345-346.
9. Branza-Nichita, N., Petrescu, A.J., Dwek, R.A., Wormald, M.R., Platt, F.M., and Petrescu, S.M. (1999). Tyrosinase folding and copper loading in vivo: A crucial role for calnexin and alpha-glucosidase II. Biochem. Biophys. Res. Commun. 261, 720-725.
10. Brilliant, M., and Gardner, J. (2001). Melanosomal pH, pink locus protein and their roles in melanogenesis. J. Invest. Dermatol. 117, 386-387.
11. Bun-ya, M., Shikata, K., Nakade, S., Yompakdee, C., Harashima, S., and Oshima, Y. (1996). Two new genes, PHO86 and PHO87, involved in inorganic phosphate uptake in Saccharomyces cerevisiae. Curr. Genet. 29, 344-351.
12. Chaudhuri, B., Ingavale, S., and Bachhawat, A.K. (1997). apd1+, a gene required for red pigment formation in ade6 mutants of Schizosaccharomyces pombe, encodes an enzyme required for glutathione biosynthesis: A role for glutathione and a glutathione-conjugate pump. Genetics 145, 75-83.
13. Chen, K., Manga, P., and Orlow, SJ. (2002). The pink eyed dilution protein controls the processing of tyrosinase. Mol. Biol. Cell 13, 1953-1964.
14. Chittur, S.V., Klem, T.J., Shafer, C.M., and Davisson, V.J. (2001). Mechanism for acivicin inactivation of triad glutamine aminotransferases. Biochemistry 40, 876-887.
15. Cho, J.E., Kim, H.S., Ahn, W.S., and Park, Y.S. (2001). Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins. J. Microencapsul. 18, 421-431.
16. Commandeur, J.N., Stijntjes, G.J., and Vermeulen, N.P. (1995). Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol. Rev. 47, 271-330.
17. Conibear, E., and Stevens, T.H. (2002). Studying yeast vacuole. Methods Enzymol. 351, 408-432.
18. Cuozzo, J.W., and Kaiser, C.A. (1999). Competition between glutathione and protein thiols for disulphide-bond formation. Nat. Cell. Biol. 1, 130-135.
19. Dai, J., Weinberg, R.S., Waxman, S., and Jing, Y. (1999). Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93, 268-277.
20. del Marmol, V., Solano, F., Sels, A., Huez, G., Libert, A., Lejeune, F., and Ghanem, G. (1993). Glutathione depletion increases tyrosinase activity in human melanoma cells. J. Invest. Dermatol. 101, 871-874.
21. Dormer, U.H., Westwater, J., McLaren, N.F., Kent, N.A., Mellor, J., and Jamieson, D.J. (2000). Cadmium-inducible expression of the yeast GSH1 gene requires a functional sulfur-amino acid regulatory network. J. Biol. Chem. 275, 32611-3266.
22. Durham-Pierre, D., Gardner, J.M., Nakatsu, Y., King, R.A., Francke, U., Ching, A., Aquaron, R., del Marmol, V., and Brilliant, M.H. (1994). African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism. Nat. Genet. 7, 176-179.
23. Egner, R., Rosenthal, F.E., Kralli, A., Sanglard, D., and Kuchler, K. (1998). Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol. Biol. Cell 9, 523-543.
24. Eton, O., et al. (2002). Sequential biochemotherapy versus chemotherapy for metastatic melanoma: Results from a phase III randomized trial. J. Clin. Oncol. 20, 2045-2052.
25. Frand, A.R., Cuozzo, J.W., and Kaiser, C.A. (2000). Pathways for protein disulphide bond formation. Trends Cell Biol. 10, 203-210.
26. Gahl, W.A., Potterf, B., Durham-Pierre, D., Brilliant, M.H., and Hearing, V.J. (1995). Melanosomal tyrosine transport in normal and pink-eyed dilution murine melanocytes. Pigment Cell Res. 8, 229-233.
27. Gardner, J.M., Nakatsu, Y., Gondo, Y., Lee, S., Lyon, M.F., King, R.A., and Brilliant, M.H. (1992). The mouse pink-eyed dilution gene: Association with human Prader-Willi and Angelman syndromes. Science 257, 1121-1124.
28. Ghosh, M., Shen, J., and Rosen, B.P. (1999). Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 96, 5001-5006.
29. Gibbs, P., Anderson, C., Peartman, N., LaClaire, S., Becker, M., Gatlin, K., O'Driscoll, M., Stephens, J., and Gonzalez, R. (2002). A phase II study of neoadjuvant biochemotherapy for stage III melanoma. Cancer 94, 470-476.
30. Halaban, R., Patton, R.S., Cheng, E., Svedine, S., Trombetta, E.S., Wahl, M.L., Ariyan, S., and Hebert, D.N. (2002). Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway. J. Biol. Chem. 25, 1-25.
31. Hearing, V.J., and King, R.A. (1993). In: Pigmentation and Pigmentary Abnormalities, ed. N. Levine, Boca Raton, FL: CRC Press, 3-32.
32. Hwang, C., Sinskey, A.J., and Lodish, H.F. (1992). Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257, 1496-1502.
33. Ito, S. (1993). High-performance liquid chromatography (HPLC) analysis of eu- and pheomelanin in melanogenesis control. J. Invest. Dermatol. 100, 166S-171S.
34. Ito, S., Fujita, K., Takahashi, H., and Jimbow, K. (1984). Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa. J. Invest. Dermatol. 83, 12-14.
35. Jara, J.R., Aroca, P., Solano, F., Martinez, J.H., and Lozano, J.A. (1988). The role of sulfhydryl compounds in mammalian melanogenesis: The effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway. Biochim. Biophys. Acta 967, 296-303.
36. King, R.A., Oettting, W.S., and Hearing, V.J. (1995). In: Metabolic and Molecular Bases of Inherited Disease, ed. S.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, New York: McGraw-Hill Book Company, 4353-4392.
37. Lamoreux, M.L., Zhou, B.K., Rosemblat, S., and Orlow, S.J. (1995). The pink eyed-dilution protein and the eumelanin/pheomelanin switch: In support of a unifying hypothesis. Pigment Cell Res. 8, 263-270.
38. Lau, W.T., Howson, R.W., Malkus, P., Schekman, R., and O'Shea, E.K. (2000). Pho86p, an endoplasmic reticulum (ER) resident protein in Saccharomyces cerevisiae, is required for ER exit of the high-affinity phosphate transporter Pho84p. Proc. Natl. Acad. Sci. USA 97, 1107-1012.
39. Lee, S.T., Nicholls, R.D., Bundey, S., Laxova, R., Musarella, M., and Spritz, R.A. (1994). Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N. Engl. J. Med. 330, 529-534.
40. Lee, S.T., Nicholls, R.D., Jong, M.T., Fukai, K., and Spritz, R.A. (1995). Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 26, 354-363.
41. Li, Z.S., Szczypka, M., Lu, Y.P., Thiele, D.J., and Rea, P.A. (1996). The yeast cadmium factor protein (YCF1) is a vacuolar glutathione S-conjugate pump. J. Biol. Chem. 271, 6509-6517.
42. Manga, P., Boissy, R.E., Pifko-Hirst, S., Zhou, B.K., and Orlow, S.J. (2001). Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type, 2 Exp. Eye. Res. 72, 695-710.
43. Manga, P., and Orlow, S.J. (2001). Inverse correlation between pink-eyed dilution protein expression and induction of melanogenesis by bafilomycin A1. Pigment Cell Res. 14, 362-367.
44. Marcusson, E.G., Horazdovsky, B.F., Cereghino, J.L., Gharakhanian, E., and Emr, S.D. (1994). The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene. Cell 77, 579-586.
45. Mehdi, K., Thierie, J., and Penninckx, M.J. (2001). γ-Glutamyl transpeptidase in the yeast Saccharomyces cerevisiae, and its role in the vacuolar transport, and metabolism of glutathione. Biochem. J. 359, 631-637.
46. Moehle, C.M., Tizard, R., Lemmon, S.K., Smart, J., and Jones, E.W. (1987) Protease B of the lysosome-like vacuole of the yeast Saccharomyces cerevisiae is homologuous to the subtilisin family of serine proteases. Moll. Cell. Biol. 7, 4390-4399.
47. Mukhopadhyay, R., Shi, J., and Rosen, B.P. (2000). Purification and characterization of ACR2p, the Saccharomyces cerevisiae arsenate reductase. J. Biol. Chem. 275, 21149-21157.
48. Murray, B.P., Zgoda, V.G., and Correia, M.A. (2002). Native CYP2C11. Heterologous expression in Saccharomyces cerevisiae reveals a role for vacuolar proteases rather than the proteasome system in the degradation of this endoplasmic reticulum protein. Mol. Pharmacol. 61, 1146-1153.
49. Nass, R., Cunningham, K.W., and Rao, R. (1997). Intracellular sequestration of sodium by a novel Na+/H+ exchanger in yeast is enhanced by mutations in the plasma membrane H+-ATPase. Insights into mechanisms of sodium tolerance. J. Biol. Chem. 272, 26145-26152.
50. Nass, R., and Rao, R. (1998). Novel localization of a Na+/H+ exchanger in a late endosomal compartment of yeast, hnplications for vacuole biogenesis. J. Biol. Chem. 273, 21054-1060.
51. Negroiu, G., Dwek, R.A., and Petrescu, S.M. (2000). Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing. J. Biol. Chem. 275, 32200-32207.
52. Oluwatosin, Y.E., and Kane, P.M. (1997). Mutations in the CYS4 gene provide evidence for regulation of the yeast vacuolar H+-ATPase by oxidation and reduction in vivo. J. Biol. Chem. 272, 28149-28157.
53. Orlow, S.J., and Brilliant, M.H. (1999). The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye. Exp. Eye Res. 68, 147-154.
54. Pinson, B., Sagot, L, and Daignan-Fornier, B. (2000). Identification of genes affecting selenite toxicity and resistance in Saccharomyces cerevisiae. Mol. Microbiol. 36, 679-687.
55. Piper, R.C., Cooper, A.A., Yang, H., and Stevens, T.H. (1995). VPS27 controls vacuolar and endocytic traffic through a prevacuolar compartment in Saccharomyces cerevisiae. J. Cell Biol. 131, 603-617.
56. Piper, R.C., Whitters, E.A., and Stevens, T.H. (1994). Yeast Vps45p is a Seclp-like protein required for the consumption of vacuole-targeted, post-Golgi transport vesicles. Eur J. Cell Biol. 65, 305-318.
57. Preston, R.A., Murphy, R.F., and Jones, E.W. (1989). Assay of vacuolar pH in yeast and identification of acidification-defective mutants. Proc. Natl. Acad. Sci. USA 86, 7027-7031.
58. Puri, N., Gardner, J.M., and Brilliant, M.H. (2000). Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. J. Invest. Dermatol. 115, 607-613.
59. Reuveny, Z. (1977). Derepression of ATP sulfurylase by the sulfate analogs molybdate and selenate in cultured tobacco cells. Proc. Natl. Acad. Sci. USA 74, 619-622.
60. Rinchik, E.M., Bultman, S.J., Horsthemke, B., Lee, S.T., Strunk, K.M., Spritz, R.A., Avidano, K.M., Jong, M.T., and Nicholls, R.D. (1993). A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 361, 72-76.
61. Rosemblat, S., Durham-Pierre, D., Gardner, J.M., Nakatsu, Y., Brilliant, M.H., and Orlow, S.J. (1994). Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proc. Natl. Acad. Sci. USA 91, 12071-12075.
62. Rosen, B.P., Weigel, U., Karkaria, C., and Gangola, P. (1988). Molecular characterization of an anion pump. The arsA gene product is an arsenite (antimonate)-stimulated ATPase. J. Biol. Chem. 263, 3067-3070.
63. Russell, L.B., Montgomery, C.S., Cacheiro, N.L., and Johnson, D.K. (1995). Complementation analyses for 45 mutations encompassing the pink-eyed dilution (p) locus of the mouse. Genetics 141, 1547-1562.
64. San Francisco, M.J., Tisa, L.S., and Rosen, B.P. (1989). Identification of the membrane component of the anion pump encoded by the arsenical resistance operon of R-factor R773. Microbiology 3, 15-21.
65. Sherman, F., Fink, G.R., and Hicks, G.B. (1986). Laboratory Course Manual for Methods in Yeast Genetics, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
66. Shrieve, D.C., Bump, E.A., and Rice, G.C. (1988). Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. J. Biol. Chem. 263, 14107-14114.
67. Sinha, R., Said, T.K., and Medina, D. (1996). Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett. 107, 277-284.
68. Siwek, B., Bahbouth, E., Serra, M.A., Sabbioni, E., de Pauw-Gillet, M.C., and Bassleer, R. (1994). Effect of selenium compounds on murine B16 melanoma cells and pigmented cloned pB16 cells. Arch. Toxicol. 68, 246-254.
69. Spritz, R.A., and Hearing, V.J. (1994). Genetic disorders of pigmentation. In: Advances in Human Genetics, ed. K. Hirschhorn and H. Harris, New York: Plenum Press, 1-45.
70. Stevens, T.H., Rothman, J.H., Payne, G.S., and Schekman, R. (1986). Gene dosage-dependent secretion of yeast vacuolar carboxypeptidase Y. J. Cell Biol. 102, 1551-1557.
71. Sviderskaya, E.V., Bennett, D.C., Ho, L., Bailin, T., Lee, S.T., and Spritz, R.A. (1997). Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J. Invest. Dermatol. 108, 30-34.
72. Szczypka, M.S., Wemmie, J.A., Moye-Rowley, W.S., and Thiele, D.J. (1994). A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. J. Biol. Chem. 269, 22853-22857.
73. Tamas, M.J., and Wysocki, R. (2001). Mechanisms involved in metalloid transport and tolerance acquisition. Curr. Genet. 40, 2-12.
74. Tamate, H.B., Hirobe, T., Wakamatsu, K., Ito, S., Shibahara, S., and Ishikawa, K. (1989). Levels of tyrosinase and its mRNA in coat-color mutants of C57BL/10J congenic mice: Effects of genic substitution at the agouti, brown, albino, dilute, and pink-eyed dilution loci. J. Exp. Zool. 250, 304-311.
75. Toh-e, A., and Oshima, Y. (1974). Characterization of a dominant, constitutive mutation, PHOO, for the repressible acid phosphatase synthesis in Saccharomyces cerevisiae. J. Bacteriol. 120, 608-617.
76. Tommasini, R., Evers, R., Vogt, E., Mornet, C., Zaman, G.J., Schinkel, A.H., Borst, P., and Martinoia, E. (1996). The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1. Proc. Natl. Acad. Sci. USA 93, 6743-6748.
77. Toyofuko, K., Valencia, J.C., Kushimoto, T., Costin, G., Virado, V.M., Viera, W.D., Ferras, V.J., and Hearing,V.J. (2002). The etiology of oculocutaneous albinism (OCA2) type II: The pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res. 15, 1-10.
78. Vida, T.A., Huyer, G., and Emr, S.D. (1993). Yeast vacuolar proenzymes are sorted in the late Golgi complex and transported to the vacuole via a prevacuolar endosome-like compartment. J. Cell Biol. 6, 1245-1256.
79. Weisman, L.S., Bacallao, R., and Wickner, W. (1987). Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle. J. Cell Biol. 105, 1539-1547.
80. Wemmie, J.A., Szczypka, M.S., Thiele, D.J., and Moye-Rowley, W.S. (1994). Cadmium tolerance mediated by the yeast AP-1 protein requires the presence of an ATP-binding cassette transporter-encoding gene, YCF1. J. Biol. Chem. 269, 32592-32597.
81. Wysocki, R., Bobrowicz, P., and Ulaszewski, S. (1997). The Saccharomyces cerevisiae ACR3 gene encodes a putative membrane protein involved in arsenite transport. J. Biol. Chem. 272, 30061-30066.
82. Yang, C.H., Kuo, M.L., Chen, J.C., and Chen, Y.C. (1999). Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells. Br. J. Cancer 81, 796-799.
83. Zadzinski, R., Maszewski, J., and Bartosz, G. (1996). Transport of Glutathione S-Conjugates in the Yeast Saccharomyces cerevisiae. Cell Biol. Int. 20, 325-330.
84. Zhang, T.D., Chen, G.Q., Wang, Z.G., Wang, Z.Y., Chen, S.J., and Chen, Z. (2001). Arsenic trioxide, a therapeutic agent for APL. Oncogene 20, 7146-7153.